Top 10 ASX Dividend Stocks for Sep 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesBiome Australia Ltd

Biome Australia Ltd

Consumer Defensive Packaged Foods
PortfolioPortfolio WatchlistWatchlist
Company price
0.405 AUD 0.00(0%)
Last update at 2026-09-28T06:10:00Z
VOLUME
267446
Market Cap
91.20M
P/E
20.00

Momentum Score

…

Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.39
Low
0.41
High
52 Week Price Range
0.20
Low
0.53
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on Biome Australia Ltd is limited; company disclosures and public filings provide sparse detail about its core operations and products, which makes a definitive assessment difficult. The company’s long-term outlook appears tied to successful commercialization of any offerings, securing partnerships or contracts, and improving revenue visibility, milestones that could support value creation if executed by management.

Principal investment risks include limited transparency and disclosure, small‑cap illiquidity, execution and commercialization risk, uncertain revenue generation and the potential need for additional financing that could dilute shareholders.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.41
Dividend Yield
-
Revenue TTM
23.88M
Revenue Per Share
0.11
Gross Profit TTM
13.72M
Debt / Equity
0.32
ROE
51.34%
Net Debt
-0.58M
ROCE
17.52%
Diluted EPS TTM
0.02

Insight News

View All

Stock Analysis

View All

Insight Announcement

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 0.53M 0.21M -1.99M -3.08M -4.54M
Net income 3.61M 0.21M -1.67M -3.08M -4.54M
Selling general administrative - 3.32M 6.31M 7.33M 2.30M
Selling and marketing expenses - 7.66M 2.89M - 3.53M
Gross profit 6.74M 11.26M 7.91M 4.67M 2.38M
Reconciled depreciation - - 0.24M 0.22M 0.08M
Ebit 1.80M -0.00M -1.82M -3.35M -4.51M
Ebitda 2.15M 0.14M -1.58M -2.76M -4.42M
Depreciation and amortization 0.35M 0.14M 0.24M - 0.08M
Operating income 1.80M 0.28M -1.67M -3.08M -4.51M
Other operating expenses 22.09M 18.14M 14.68M 0.08M 8.89M
Interest expense 0.11M 0.20M 0.17M 0.11M 0.03M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - - 0.06M 0.02M -
Net interest income - - -0.10M -0.10M -0.05M
Income tax expense -3.08M - -0.31M - 0.31M
Total revenue 23.88M 18.42M 13.01M 7.63M 4.11M
Total operating expenses 4.94M 10.98M 9.58M - 7.15M
Cost of revenue 17.14M 7.16M 5.10M 2.96M 1.74M
Total other income expense net -1.27M -0.06M -0.31M 0.37M 0.28M
Net income from continuing ops - - -1.67M -3.08M -4.54M
Net income applicable to common shares - 0.21M -1.67M -3.08M -4.54M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 15.72M 11.97M 8.28M 7.56M 8.25M
Intangible assets 0.45M 0.16M - - -
Other current assets 0.30M 0.26M 0.08M 0.05M 0.06M
Total liab 6.34M 7.29M 5.37M 3.97M 1.73M
Total stockholder equity 9.38M 4.68M 2.90M 3.59M 6.53M
Other current liab 0.83M 0.56M 1.52M - 0.26M
Common stock 24.19M 23.32M 21.73M 20.76M 20.64M
Capital stock - - - 20.76M 20.64M
Retained earnings -15.31M -19.05M -19.27M -17.60M -14.53M
Other liab - - - 0.07M -
Cash 3.55M 2.75M 2.87M 2.26M 5.49M
Total current liabilities 5.45M 7.18M 5.14M 2.99M 1.35M
Net debt -0.58M 0.33M -1.56M - -5.03M
Short term debt 2.16M 3.02M 1.13M 0.00M 0.09M
Short long term debt - - - 0.13M -
Short long term debt total 2.97M 3.07M 1.31M - 0.47M
Other stockholder equity - - - 0.42M 0.42M
Property plant equipment - - - 0.79M 0.61M
Total current assets 11.56M 11.44M 7.71M 6.77M 7.64M
Net tangible assets - - - 3.59M 6.53M
Net receivables 3.73M 4.33M 2.87M 1.44M 0.79M
Long term debt - - - 0.65M -
Inventory 3.98M 4.11M 1.89M 3.02M 1.17M
Accounts payable 2.46M 3.60M 2.49M 2.27M 0.99M
Accumulated other comprehensive income 0.49M 0.41M 0.44M - 0.42M
Non currrent assets other - - -0.00M - -
Non current assets total 4.15M 0.53M 0.57M 0.79M 0.61M
Capital lease obligations - - - 0.38M 0.47M
Long term debt total - - - 0.92M 0.38M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.02M -0.40M -0.10M
Change to liabilities - - - 1.13M -0.09M
Total cashflows from investing activities -0.49M -0.20M -0.02M -0.40M -0.10M
Net borrowings - - 0.25M 0.68M -0.14M
Total cash from financing activities -0.33M 2.90M 0.79M 0.67M 8.40M
Change to operating activities - - - 0.43M 0.27M
Net income 3.61M 0.21M -1.67M -3.08M -4.54M
Change in cash 0.80M -0.12M 0.61M -3.23M 4.88M
Begin period cash flow 2.75M 2.87M 2.26M 5.49M 0.61M
End period cash flow 3.55M 2.75M 2.87M 2.26M 5.49M
Total cash from operating activities 1.63M -2.82M -0.16M -3.50M -3.42M
Issuance of capital stock - - 0.64M 0.00M 9.68M
Depreciation 0.35M 0.24M 0.24M 0.22M 0.08M
Other cashflows from investing activities - -0.16M - 0.00M 0.03M
Dividends paid - - - - -0.17M
Change to inventory 0.14M -2.23M 1.13M -1.72M -0.15M
Change to account receivables 0.56M -1.63M -1.46M -0.65M -0.06M
Sale purchase of stock - 1.15M 0.64M 0.00M -1.14M
Other cashflows from financing activities -0.21M 0.03M -0.10M -0.01M 0.11M
Change to netincome - - - 0.17M 1.07M
Capital expenditures 0.20M 0.04M 0.02M 0.40M 0.13M
Change in working capital -2.72M -4.99M 0.91M 0.08M 0.05M
Stock based compensation - 0.41M - - -
Other non cash items 0.39M 1.31M 0.36M - -
Free cash flow 1.42M -2.86M -0.19M -3.90M -0.13M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BIO
Biome Australia Ltd		 -
-%		 0.41 20.00 - 3.82 10.21 3.99 56.84
A2M
The a2 Milk Company Ltd		 0.06
0.90%		 6.71 28.57 26.81 2.43 5.56 2.64 16.51
BGA
Bega Cheese Ltd		 -0.04
0.66%		 6.04 33.83 22.08 0.49 1.84 0.57 11.38
CBO
Cobram Estate Olives Ltd		 0.03
1.09%		 2.78 - - 4.95 2.66 7.00 195.90
RIC
Ridley Corporation Ltd		 -0.05
1.94%		 2.53 37.00 13.02 0.34 1.95 0.52 4.41

Profile*

Biome Australia Ltd

Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.

192-194 Johnston Street, Collingwood, VIC, Australia, 3066

61 3 9017 5800

https://www.biomeaustralia.com

Name Title Year Born
Mr. Blair William Brabin Vega Norfolk MD, CEO & Director NA
Mr. Douglas Chee Yong Loh CPA Chief Financial Officer NA
Dr. Jaroslav Haman Boublik Chief Science Officer & Member of Scientific Advisory Board NA
Mr. George Lazarou ACA, BCom Company Sec. NA
Mr. Blair William Brabin Vega Norfolk MD, CEO & Director 1985
Mr. George Lazarou ACA, BCom Company Secretary NA
Mr. Blair William Brabin Vega Norfolk MD, CEO & Director 1985
Mr. George Lazarou ACA, BCom Company Secretary NA
Mr. Blair William Brabin Vega Norfolk MD, CEO & Director 1985
Mr. George Lazarou ACA, BCom Company Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ATM
AUD 1.06
+8.67%
G6M
AUD 3.49
+7.06%
NST
AUD 23.47
+6.15%
INA
AUD 4.76
+5.78%
MEZ
AUD 4.53
+5.35%
KAR
AUD 1.55
-12.89%
NMG
AUD 0.07
-12.66%
MI6
AUD 0.84
-10.64%
BRE
AUD 3.56
-9.64%
CXO
AUD 0.32
-8.70%

Equity Sectors*

  • Basic Materials

    -2.53%

  • Communication Services

    -0.20%

  • Consumer Cyclical

    -0.30%

  • Consumer Defensive

    -0.14%

  • Energy

    -1.70%

  • Financial Services

    -0.11%

  • Healthcare

    -0.80%

  • Industrials

    -0.68%

  • Real Estate

    +0.72%

  • Technology

    -0.78%

  • Utilities

    +2.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…